GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.2002
-0.0248 (-11.02%)
At close: Apr 2, 2025, 4:00 PM
0.1900
-0.0102 (-5.09%)
After-hours: Apr 2, 2025, 7:56 PM EDT
GlucoTrack Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
2.08M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GCTK News
- 2 days ago - Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 14 days ago - Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes - GlobeNewsWire
- 5 weeks ago - Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member - GlobeNewsWire
- 2 months ago - Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering - GlobeNewsWire
- 2 months ago - Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - GlobeNewsWire
- 2 months ago - Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer - GlobeNewsWire
- 2 months ago - Glucotrack Announces ISO 13485:2016 Certification - GlobeNewsWire
- 2 months ago - Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs - GlobeNewsWire